Hepatology International

Race/ethnicity-based temporal changes in prevalence of NAFLD-related advanced fibrosis in the United States, 2005–2016

Retrospective comparison of EASL 2018 and LI-RADS 2018 for the noninvasive diagnosis of hepatocellular carcinoma using magnetic resonance imaging

Clinical immunology and immunotherapy for hepatocellular carcinoma: current progress and challenges

Correction to: Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update

Chinese guidelines on the management of ascites and its related complications in cirrhosis

Finite nucleos(t)ide analog therapy in HBeAg-negative chronic hepatitis B: an emerging paradigm shift

New drugs for NAFLD: lessons from basic models to the clinic

Association of epicardial adipose tissue with non-alcoholic fatty liver disease: a meta-analysis

Complications constitute a major risk factor for mortality in hepatitis B virus-related acute-on-chronic liver failure patients: a multi-national study from the Asia–Pacific region

Non-obese histologically confirmed NASH patients with abnormal liver biochemistry have more advanced fibrosis

Circulating tumor cells are associated with poor outcomes in early-stage hepatocellular carcinoma: a prospective study

Sofosbuvir–velpatasvir single-tablet regimen administered for 12 weeks in a phase 3 study with minimal monitoring in India

Significant decrease in Faecalibacterium among gut microbiota in nonalcoholic fatty liver disease: a large BMI- and sex-matched population study

Management of HCV-related decompensated cirrhosis with direct-acting antiviral agents: who should be treated?

Prediction and clinical implications of HBV reactivation in lymphoma patients with resolved HBV infection: focus on anti-HBs and anti-HBc antibody titers

Preoperative transcatheter arterial chemoembolization for surgical resection of huge hepatocellular carcinoma (≥\u200910 cm): a multicenter propensity matching analysis

Prognostic subclass of intrahepatic cholangiocarcinoma by integrative molecular–clinical analysis and potential targeted approach

MicroRNA-744/transforming growth factor β1 relationship regulates liver cirrhosis

Long-term efficacy and safety of tenofovir disoproxil fumarate in Chinese patients with chronic hepatitis B: 5-year results

Immunological recovery in T-cell activation after sustained virologic response among HIV positive and HIV negative chronic Hepatitis C patients

Current status and perspectives for computer-aided ultrasonic diagnosis of liver lesions using deep learning technology

An imbalance between stellate cells and γδT cells contributes to hepatocellular carcinoma aggressiveness and recurrence

Biliary features in liver histology of children with autoimmune liver disease

Generic sofosbuvir/ledipasvir for the treatment of genotype 4 chronic hepatitis C in Egyptian children (9–12 years) and adolescents

Pegylated-interferon consolidation treatment versus nucleos(t)ide analogue consolidation treatment in non-cirrhotic hepatitis B patients with hepatitis B e antigen seroconversion: an open-label pilot trial

The prognostic role of liver stiffness in patients with chronic liver disease: a systematic review and dose–response meta-analysis

The change in the nationwide seroprevalence of hepatitis C virus and the status of linkage to care in South Korea from 2009 to 2015

Sequential combination therapy with interferon, interleukin-2 and therapeutic vaccine in entecavir-suppressed chronic hepatitis B patients: the Endeavor study

Targeting adenosinergic pathway enhances the anti-tumor efficacy of sorafenib in hepatocellular carcinoma

Change in antibiotic regimen for emerging multidrug resistance in nosocomial ascitic fluid infection

Ascitic fluid infection in children with liver disease: time to change empirical antibiotic policy

Is there increased risk of hepatocellular carcinoma recurrence in liver transplant patients with direct-acting antiviral therapy?

SHG/TPEF-based image technology improves liver fibrosis assessment of minimally sized needle biopsies

Bacteroides in colonic mucosa-associated microbiota affects the development of minimal hepatic encephalopathy in patients with cirrhosis

Laser capture microdissection: techniques and applications in liver diseases

Plasminogen activator inhibitor 2 (PAI2) inhibits invasive potential of hepatocellular carcinoma cells in vitro via uPA- and RB/E2F1-related mechanisms

Mutations in CYP2C9 and/or VKORC1 haplotype are associated with higher bleeding complications in patients with Budd–Chiari syndrome on warfarin

Association between neutrophil–lymphocyte ratio, socioeconomic status, and ethnic minority with treatment outcome in hepatocellular carcinoma

Use of HBsAg quantification in the natural history and treatment of chronic hepatitis B

Refining the role of epicardial adipose tissue in non-alcoholic fatty liver disease

Point shear wave elastography predicts fibrosis severity and steatohepatitis in alcohol-related liver disease

Sarcopenia: an emerging risk factor for non-alcoholic fatty liver disease

Association of acute-on-chronic liver failure with vascular liver diseases

Correction to: Antifibrotics in liver disease: are we getting closer to clinical use?

New treatment-induced adverse effects we need to learn as modern hepatologists